Aspiration pneumonitis and pneumonia

[1]

Pneumonitis vs pneumonia — the core distinction

A single aspiration event can produce two entirely different syndromes, and the difference determines whether antibiotics are given. Confusing the two is one of the commonest antibiotic-stewardship errors in the ICU: up to a third of inpatients labelled "aspiration pneumonia" actually have sterile pneumonitis for which antibiotics add nothing and cause harm (Clostridioides difficile colitis, resistance, adverse drug events, cost).[1][6]

[1] [2] [1]

Definition and classification

Aspiration pneumonitis (Mendelson syndrome) is the acute chemical lung injury produced by inhalation of sterile, acidic gastric contents. It is the syndrome Curtis Mendelson described in 1946 after observing 66 aspirations among 44,016 obstetric anaesthetics — establishing the chemical-injury paradigm and the rationale for fasting and airway protection that still underpins modern anaesthetic practice.[3]

Aspiration pneumonia is the bacterial infection of the lung produced by inhalation of bacteria-laden oropharyngeal or gastric secretions. The two are distinguished by mechanism (chemical vs bacterial), tempo (hours vs 24-48 h), and — crucially — by whether antibiotics are indicated.[1]

A third entity, aspiration of particulate matter (food particles, foreign body, teeth), produces mechanical obstruction and post-obstructive infection and is managed by bronchoscopic retrieval rather than antibiotics or lavage. [1]

Pathophysiology — the Mendelson cascade

The injuring agent in aspiration pneumonitis is the acid itself, which is precisely why antibiotics, corticosteroids, and lavage do not alter the acute chemical injury.[1][4]

The biphasic acid-injury cascade

Kennedy and colleagues (1989) established the biphasic nature of acid aspiration lung injury in a landmark animal model, an insight now central to every exam answer:[5]

1. Phase 1 (0-1 h) — direct chemical burn. Acid reaches the alveoli and spreads throughout the bronchial tree within 12 to 18 seconds. Below pH 2.5 it causes immediate coagulative necrosis of bronchial and alveolar epithelium. The alveolar-capillary membrane is disrupted within minutes, allowing a protein-rich exudate to flood the alveoli — a non-cardiogenic pulmonary oedema.
2. Phase 2 (1-6 h) — neutrophil-mediated amplification. Neutrophil infiltration releases reactive oxygen species, proteases and leukotrienes that amplify the injury. This is acute inflammation, NOT infection, but it is the phase that drives progression to ARDS. Surfactant is inactivated, compliance falls, atelectasis follows.
3. Resolution (24-72 h) in most cases — but roughly 10% of massive aspirations progress to ARDS by 24-36 h, and a subset develop secondary bacterial infection over subsequent days.[4]

[4] [1]

Why hypoxaemia is out of proportion to the early CXR

Surfactant inactivation and alveolar flooding produce V/Q mismatch and intrapulmonary shunt. The patient is hypoxaemic, often markedly, while the chest X-ray may still look near-normal — a classic exam pearl and a source of missed early severity.[4]

Pneumonia — bacterial overgrowth in dependent lung

An aspirated bacterial inoculum overwhelms mucociliary clearance and alveolar macrophages in dependent, poorly ventilated segments. Anaerobic, low-oxygen-tension micro-environments (atelectasis, necrotic tissue) favour anaerobe proliferation. Necrotising anaerobes (Fusobacterium, Bacteroides) drive tissue destruction → cavitation, lung abscess, necrotising pneumonia, empyema. Dental plaque (biofilm) is the reservoir for anaerobes, which is why dentition and oral hygiene are the key modifiable risk factors.[8]

Epidemiology

• Aspiration is common in the ICU: micro-aspiration around the endotracheal tube is near-universal in ventilated patients and is the principal mechanism of ventilator-associated pneumonia.[7]
• Aspiration pneumonia accounts for 5-15% of community-acquired pneumonia and up to 20% of pneumonia in the elderly and nursing-home residents.[2]
• Mendelson's original 1946 series observed aspiration in 0.15% of obstetric anaesthetics; modern fasting and airway practice has made aspiration during anaesthesia uncommon, but it remains a leading cause of anaesthesia-related morbidity when it occurs.[3]
• Hospitalised aspiration pneumonia mortality is 20-30%, higher in the elderly, nursing-home residents, and those with recurrent aspiration or multiple comorbidities.[1]

Risk factors for aspiration

All risk factors converge on two mechanisms: impaired airway protection and increased bacterial inoculum.[2]

Reduced consciousness / protective reflexes

• Decreased GCS — stroke (especially brainstem or large MCA territory), post-ictal state after seizure, traumatic head injury, metabolic encephalopathy (hepatic, uraemic, hyperosmolar)
• Intoxication — alcohol, opioids, benzodiazepines
• Anaesthesia and procedural sedation — especially emergency or non-fasted cases; the setting of Mendelson's original 1946 description
• ICU sedation — minimised by daily sedation interruption (SAT) and spontaneous awakening trials [1]

Neurological and swallowing impairment

• Acute stroke — dysphagia in up to 50%; pneumonia risk is highest in the first 72 hours, and a formal swallow screen prevents pneumonia[9]
• Bulbar palsy / weakness — myasthenia gravis, Guillain-Barré syndrome, motor neuron disease, multiple sclerosis, brainstem stroke
• Dementia, Parkinson's disease
• Post-extubation dysphagia — common after >48 h intubation (cuff-related laryngeal injury, recurrent laryngeal nerve neuropraxia)

Mechanical and anatomical

• Gastro-oesophageal reflux disease (GERD), obesity, pregnancy (increased intra-abdominal pressure, delayed gastric emptying, reduced lower oesophageal sphincter tone)
• Nasogastric tube — splints the lower oesophageal sphincter and causes stasis; a key iatrogenic risk factor
• Mechanical ventilation — micro-aspiration around the cuff, especially with low cuff pressure, patient-ventilator dys-synchrony, or reintubation
• Oesophageal disorders — achalasia, Zenker's diverticulum, stricture, scleroderma
• Feeding tubes / tracheostomy / vocal cord palsy
• Gastrointestinal obstruction, recent upper GI surgery [1]

Increased bacterial load / colonisation

• Poor dentition and periodontal disease — the reservoir for anaerobes
• Poor oral hygiene — addressed by chlorhexidine oral care and toothbrushing
• Proton-pump inhibitor use — raises gastric pH and permits gastric colonisation with Gram-negatives
• Chronic or recurrent micro-aspiration — elderly, nursing-home residents, recent antibiotics [1]

[2] [7]

Causative organisms (pneumonia only)

Aspiration pneumonia — the classic anaerobic + aerobic mix

Anaerobes (originate from gingival crevices and dental plaque; need anaerobic transport and are rarely recovered from expectorated sputum):

• Peptostreptococcus species — the single most common anaerobe
• Fusobacterium nucleatum — necrotising
• Prevotella, Bacteroides (including the B. fragilis group in abscess)
• Porphyromonas, Actinomyces (chronic, indolent infection) [1]

Aerobes:

• Streptococcus pneumoniae, Haemophilus influenzae — community-acquired
• Staphylococcus aureus (including MRSA)
• Enteric Gram-negative bacilli — Klebsiella, E. coli, Pseudomonas — more prominent in healthcare-associated aspiration, alcoholism, and structural lung disease[8]

[8]

Aspiration pneumonitis

Sterile — no organism. If secondarily infected, expect the same oropharyngeal flora as above. Antibiotics given "just in case" select for resistant organisms without preventing infection.[1][6]

[2] [13]

Clinical features and radiology

• Onset — pneumonitis within hours; pneumonia over 24 to 48 hours (or insidious in the elderly)
• Dyspnoea, tachypnoea, tachycardia; fever, purulent sputum and leucocytosis favour infection
• Crackles, bronchial breathing, decreased breath sounds over dependent zones; wheeze from bronchospasm
• Hypoxaemia — classically out of proportion to the chest X-ray early in pneumonitis [1]

Radiographic distribution — gravity dictates the site

[1]

Imaging patterns

• Pneumonitis — bilateral patchy or perihilar infiltrates within hours; may evolve into an ARDS-pattern of diffuse alveolar and interstitial opacities
• Pneumonia — focal consolidation in dependent segments; ± cavitation or abscess (anaerobes), effusion or empyema, necrotising pneumonia
• CT chest — more sensitive than CXR for cavitation, abscess, empyema, necrosis, and an aspirated foreign body [1]

Investigations

• Bloods — FBC, EUC, LFTs, CRP, procalcitonin (low in pneumonitis < 0.1, high in bacterial infection > 0.25 — the best biochemical discriminator)[6]
• ABG/VBG — quantify hypoxaemia, the A-a gradient, and acid-base status
• Chest X-ray on presentation and serially; CT chest if cavitation, abscess, empyema suspected or for poor-resolution cases
• Blood cultures before antibiotics (in pneumonia or sepsis)
• Sputum / endotracheal aspirate Gram stain and culture — aerobic; anaerobic culture of expectorated sputum is unhelpful (oral contamination)
• Invasive sampling (bronchoscopic BAL, protected specimen brush) — for severe, healthcare-associated, immunocompromised, or non-responding cases
• Bronchoscopy — for retrieval of large particulate / food / foreign body aspiration; not for lavage of acidic liquid

Management

The immediate goal is airway protection and oxygenation; the secondary goal is the disciplined antibiotic decision. Both rest on the pneumonitis-vs-pneumonia distinction.[1]

[1] [2]

1. Immediate airway and respiratory support

• Airway — clear and protect the airway; suction the oropharynx; intubate if GCS ≤ 8, unable to protect the airway, or severe hypoxaemia
• Oxygen — target SpO₂ 92-96 per cent (88-92 per cent if COPD/hypercapnia risk)
• Ventilatory support — NIV may avoid intubation in moderate pneumonitis (each intubation raises VAP risk); invasive ventilation for refractory hypoxaemia or ARDS
• Positioning — head of bed elevated; lateral with the affected side down to localise the process
• Fluids — judicious; capillary leak favours cautious resuscitation, but hypovolaemia worsens perfusion [1]

2. The antibiotic decision — the stewardship core

Aspiration pneumonitis → NO empirical antibiotics. Reassess at 48 to 72 hours and start only if infection develops (fever, purulent sputum, leucocytosis, progressive infiltrates), or if there is high baseline suspicion of bacterial co-infection (sepsis, immunocompromise, institutionalised, recent antibiotics).[1][6]

Aspiration pneumonia → antibiotics covering aerobes + anaerobes:[2][13]

• Community-acquired, mild to moderate — amoxicillin-clavulanate OR clindamycin (± a respiratory fluoroquinolone)
• Severe / hospitalised — piperacillin-tazobactam OR clindamycin + ceftriaxone (or cefepime + metronidazole)
• Healthcare-associated / MDR risk — extended-spectrum antipseudomonal β-lactam (pip-tazo, cefepime, meropenem) ± MRSA cover (vancomycin or linezolid)
• Abscess / empyema — drain + prolonged anaerobic cover (4-6 weeks) [1]

[13] [14]

3. Therapies NOT recommended

4. Supportive and adjunctive care

• Lung-protective ventilation for ARDS — VT 6 mL/kg predicted body weight, plateau pressure < 30 cmH₂O, PEEP titrated (ARDSNet 2000)[15][16]
• Chest physiotherapy — postural drainage, percussion, breathing exercises once the patient is stable
• Bronchodilators for bronchospasm
• VAP prevention bundle (see below)
• DVT and stress-ulcer prophylaxis per ICU protocol
• Early enteral nutrition via NG or NJ with swallow reassessment before any oral intake

The antibiotic stewardship argument in detail

Prophylactic or empirical antibiotics for aspiration pneumonitis are one of the commonest mis-prescriptions in hospital medicine. The case against them rests on three legs:[1][6]

1. They do not work. The acute injury is chemical and sterile. Antibiotics cannot prevent neutrophil-mediated amplification or secondary infection; multiple studies show no reduction in subsequent pneumonia.
2. They cause harm. Selection of resistant organisms, Clostridioides difficile colitis, adverse drug events, and cost. Up to a third of inpatients labelled "aspiration pneumonia" actually have sterile pneumonitis.
3. They mask the diagnosis. Empirical antibiotics obscure the later emergence of true infection by altering cultures and inflammatory trends. [1]

The stewardship-friendly approach is a 48-72 hour observation window with serial procalcitonin, CRP, temperature, and repeat imaging, with antibiotics reserved for declared infection or high baseline risk. Singh and colleagues showed that clinical and procalcitonin-guided stopping rules safely shortened antibiotic courses in ICU patients with pulmonary infiltrates — the evidence base for the observation window.[6]

Aspiration prophylaxis bundle (prevention)

The most effective "treatment" for aspiration is prevention. The following evidence-based measures reduce aspiration in ICU and other high-risk patients.[7]

1. Head of bed elevation 30 to 45 degrees — the strongest single intervention; Drakulovic 1999 showed a semi-recumbent (45°) vs supine position near-halved nosocomial pneumonia in mechanically ventilated patients[10]
2. Oral care with chlorhexidine (0.12 per cent or 0.2 per cent) every 4 to 6 hours — reduces oropharyngeal bacterial load
3. Subglottic suctioning endotracheal tube (continuous or intermittent) — removes pooled contaminated secretions above the cuff
4. Cuff pressure management 20 to 30 cmH₂O — check every 8 to 12 hours; avoid under-inflation (leak and micro-aspiration) and over-inflation (mucosal ischaemia)
5. Minimise sedation — daily sedation interruption, spontaneous awakening trials, spontaneous breathing trials; the awake patient protects their own airway
6. Avoid unnecessary reintubation — each intubation or reintubation event multiplies VAP and aspiration risk
7. Swallow assessment (speech-language therapist) before any oral intake in stroke and post-extubation patients[9]
8. Good oral hygiene — toothbrushing and denture care, not chlorhexidine alone
9. Enteral feeding safeguards — jejunal rather than gastric feeding if aspiration risk is high; prokinetics; small-bore tube; post-pyloric placement
10. Review stress-ulcer prophylaxis — balance the risk (a PPI raises gastric pH and promotes Gram-negative gastric colonisation) against benefit (indicated only in high-risk patients: mechanically ventilated > 48 h, coagulopathy, major burns)

Special situations

Anaesthesia — Mendelson's origin

The setting of Mendelson's original 1946 description (obstetric anaesthesia). Modern practice — fasting, rapid sequence induction (RSI) with cricoid pressure, securing the cuff before ventilation, and avoiding positive-pressure mask ventilation in the at-risk patient — has made aspiration during anaesthesia uncommon but it remains a leading cause of anaesthesia-related morbidity when it occurs.[3]

Pregnancy

Historically a leading cause of maternal anaesthetic death. The combination of increased intra-abdominal pressure, delayed gastric emptying, and reduced lower oesophageal sphincter tone makes the parturient high-risk; RSI with a cuffed tube is standard. This is the exact population Mendelson studied. [1]

Acute stroke

Up to 50 per cent of acute stroke patients have dysphagia, and aspiration pneumonia is the commonest medical complication. A formal dysphagia screen within 4 hours of admission and keeping the patient NPO until swallow is cleared reduce pneumonia significantly.[9] Texture-modified diets and fluid thickeners are used per SLT assessment, recognising that thickened fluids themselves may increase dehydration and are not uniformly protective.

Post-extubation dysphagia

Common after more than 48 hours of intubation — cuff-related laryngeal injury and recurrent laryngeal nerve neuropraxia cause transient swallow impairment. Screen before restarting oral intake; the majority recover within days to weeks. [1]

Complications and prognosis

• ARDS — roughly 10 per cent of massive aspiration pneumonitis progresses to ARDS (Berlin definition: acute onset, bilateral opacities, PaO₂/FiO₂ ≤ 300 with PEEP ≥ 5, not fully explained by cardiac failure)[16]; mortality rises sharply
• Secondary bacterial pneumonia — supervenes on a fraction of pneumonitis cases
• Lung abscess and necrotising pneumonia — typically anaerobic (Fusobacterium, Bacteroides); may need percutaneous or surgical drainage plus prolonged antibiotics
• Empyema — requires chest-tube drainage ± surgical decortication
• Death — hospitalised aspiration pneumonia mortality is 20 to 30 per cent, higher in the elderly and nursing-home residents[1]

Prognosis

• Pneumonitis — most cases resolve within 24 to 72 hours with supportive care; mortality rises sharply if ARDS develops
• Aspiration pneumonia — hospitalised mortality 20 to 30 per cent; higher in the elderly, nursing-home residents, and those with recurrent aspiration or multiple comorbidities
• Recurrence — the patient who aspirates once is at high risk of repeating; address the underlying cause (swallow, dentition, feeding route, sedation) [1]

Evidence and trials

Additional clinical pearls — exam-exhaustive

[1] [1]

Red flags

[1]

References

1. [1]Marik PE. Aspiration pneumonitis and aspiration pneumonia N Engl J Med, 2001.PMID 11228282
2. [2]DiBardino DM, Wunderink RG. Aspiration pneumonia: a review of modern trends J Crit Care, 2015.PMID 25129577
3. [3]Mendelson CL. The aspiration of stomach contents into the lungs during obstetric anesthesia Am J Obstet Gynecol, 1946.PMID 20993766
4. [4]Raghavendran K, Nemzek J, Napolitano LM, Knight PR. Aspiration-induced lung injury Crit Care Med, 2011.PMID 21263315
5. [5]Kennedy TP, Johnson KJ, Kunkel RG, Ward PA, Finch JS, Hoidal JR. Acute acid aspiration lung injury in the rat: biphasic pathogenesis Anesth Analg, 1989.PMID 2742173
6. [6]Singh N, Rogers P, Atwood CW, Wagner MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription Am J Respir Crit Care Med, 2000.PMID 10934078
7. [7]Klompas M, Branson R, Eichenwald EC, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update Infect Control Hosp Epidemiol, 2014.PMID 25376073
8. [8]El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly Am J Respir Crit Care Med, 2003.PMID 12689848
9. [9]Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S. Formal dysphagia screening protocols prevent pneumonia Stroke, 2005.PMID 16109909
10. [10]Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial Lancet, 1999.PMID 10584721
11. [11]Sukumaran M, Granada MJ, Berger HW, Lee M, Reilly TA. Evaluation of corticosteroid treatment in aspiration of gastric contents: A controlled clinical trial Mt Sinai J Med, 1980.PMID 6997729
12. [12]Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome N Engl J Med, 1987.PMID 3317054
13. [13]Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis, 2007.PMID 17278083
14. [14]Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America Am J Respir Crit Care Med, 2019.PMID 31573350
15. [15]Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med, 2000.PMID 10793162
16. [16]ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition JAMA, 2012.PMID 22797452